This work aims to investigate the genetic alterations and protein expression of RECQL4 in gliomas and neurofibromatosis type 1-associated neoplasms and their correlation to ALT and related molecular mechanisms and to assess the role of RECQL4-knockdown cells in survival and susceptibility to ATR-kinase inhibitors. Here, RECQL4 is linked to central nervous system cancer.